LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Nutanix’s stock rises on earnings, revenue beats

Clyde Edgerton by Clyde Edgerton
November 29, 2023
in Markets
Nutanix’s stock rises on earnings, revenue beats
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


You might also like

Inside Trump’s chainsaw-wielding approach to one corner of government contracting

Trump’s chaotic economy is causing headaches for Democrats in New Jersey's governor race

Warren Buffett shocks shareholders by announcing his intention to retire at the end of the year

Nutanix Inc.’s
NTNX,
+2.59%
stock jumped more than 6% in extended trading Wednesday after the cloud-software company reported quarterly results that eclipsed analyst revenue and earnings estimates. Nutanix reported a fiscal-first-quarter net loss of $15.8 million, or 7 cents a share, compared with a net loss of $99.5 million, or 44 cents a share, in the same quarter a year ago. Adjusted earnings were 29 cents a share. Revenue was $511 million, compared with $433.6 million in the same quarter a year ago. Analysts surveyed by FactSet had expected on average net earnings of 18 cents a share on revenue of $501 million. “AI is a long-term event at all levels for our enterprise customers, but many of them are in an experimental phase,” Nutanix Chief Executive Rajiv Ramaswami said in an interview. “What we do is very central for any company going through a digital transformation and cost conscious.” Nutanix’s stock has propelled 59.5% this year, while the broader S&P 500 index
SPX,
-0.09%
has increased 18.5%.



Source link

Share30Tweet19
Previous Post

UAW launches campaign to unionize all automakers at once – Tesla, Toyota, etc

Next Post

Monitoring abnormal cells ‘could increase cervical cancer risk in long term’

Clyde Edgerton

Clyde Edgerton

Recommended For You

Inside Trump’s chainsaw-wielding approach to one corner of government contracting
Markets

Inside Trump’s chainsaw-wielding approach to one corner of government contracting

May 25, 2025
Trump’s chaotic economy is causing headaches for Democrats in New Jersey's governor race
Markets

Trump’s chaotic economy is causing headaches for Democrats in New Jersey's governor race

May 14, 2025
Warren Buffett shocks shareholders by announcing his intention to retire at the end of the year
Markets

Warren Buffett shocks shareholders by announcing his intention to retire at the end of the year

May 3, 2025
Dems see Trump as vulnerable on the economy — if they can come up with an alternative
Markets

Dems see Trump as vulnerable on the economy — if they can come up with an alternative

April 30, 2025
Next Post
Monitoring abnormal cells ‘could increase cervical cancer risk in long term’

Monitoring abnormal cells ‘could increase cervical cancer risk in long term’

Related News

ETF outlook: Why Wall Street strategists aren’t chasing a growth stock trade just yet

ETF outlook: Why Wall Street strategists aren’t chasing a growth stock trade just yet

April 1, 2023
Binance kicks off transition to new platform in Japan

Binance kicks off transition to new platform in Japan

May 27, 2023
Truss joins calls by senior Tories to scrap inheritance tax

Truss joins calls by senior Tories to scrap inheritance tax

June 1, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?